Linear covariate analysis of prognostically significant metabolites. Presenting the effect sizes of metabolites that showed significant differences among prognostic groups in ICU-treated COVID-19 patients. Metabolites were included based on an F-value > 2.5 and a p-value < 0.05. Metabolites marked with a single asterisk (*) were significant in both two-way ANOVA and ASCA, whereas those marked with double asterisks (**) were significant only in two-way ANOVA. Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease. by Emir Matpan (21655811)

“…Positive effect sizes indicate an increase in metabolite concentration between the compared groups, while negative values indicate a decrease.…”

Estimated infection intensity (mean egg count per gram) for infected stools. by Roland Proud (11764892)

Subjects:

Spearman’s correlation matrix of weather conditions, both mean (x̄) and maximum, against daily number of visits to the water trough, mean water intake per visit, and mean water int... by M. Jordana Rivero (14610947)

The mean and standard error of take-over reaction time for type A, type B, and type C autonomous driving information display types under various scenario complexities. by Chengmin Zhou (14554562)

Training impact on electrical properties of P3 lumbar MNs. Rin: input resistance. Rheobase: lowest intensity of current injected in MNs to elicit an action potential (AP). AP threshold: voltage measured at the foot of the AP. AP amplitude: measured between the resting membrane potential and the AP peak. AP half width: time spent by the potential > 50% of the AP maximum amplitude. AP rise time: time spent by the potential between 10% and 90% of the AP maximum amplitude. AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential. All values are means ± SEM. The number of MNs recorded is indicated between brackets. ns: no significantly different.... by Camille Quilgars (21156495)

“…All values are means ± SEM. The number of MNs recorded is indicated between brackets. ns: no significantly different. …”

Passive sensing data. by Thierry Jean (20691795)

Subjects:

Surveys. by Thierry Jean (20691795)

Subjects:

Glucose consumption and lactate release of alveolar macrophages of MH-S cell line stimulated with SMPs and other glucans. by Alejandra Barrera-Rosales (21656278)

Subjects:

Cell viability of alveolar macrophages of MH-S cell line stimulated with SMPs for 24 by Alejandra Barrera-Rosales (21656278)

Subjects:

Production of nitric oxide in alveolar macrophages of MH-S cell line stimulated with SMPs and glucans evaluated by Griess. by Alejandra Barrera-Rosales (21656278)

Subjects:

Phagocytosis of SMPs by alveolar macrophages of MH-S cell line evaluated by flow cytometry. by Alejandra Barrera-Rosales (21656278)

Subjects:

Secretion of cytokines in alveolar macrophages of MH-S cell line stimulated with SMPs and other glucans. by Alejandra Barrera-Rosales (21656278)

Subjects:

Time course of optical coherence tomography and fundus findings in a representative non-recurrent eye. by Yasuyuki Sotani (20114144)

Subjects:

Time course of central retinal thickness (CRT) in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Time course of best-corrected visual acuity (BCVA) in all eyes. by Yasuyuki Sotani (20114144)

Subjects:

Annual number of outpatient visits in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Time course of central retinal thickness (CRT) in all eyes. by Yasuyuki Sotani (20114144)

Subjects:

Annual treatment frequencies in all eyes. by Yasuyuki Sotani (20114144)

Subjects:

Annual treatment frequencies in recurrence and non-recurrence groups. by Yasuyuki Sotani (20114144)

Subjects:

Preoperative background characteristics of the patients. by Yasuyuki Sotani (20114144)

Subjects: